[EN] RESORCINOL DERIVATIVES AS HSP90 INHIBITORS<br/>[FR] DÉRIVÉS DU RÉSORCINOL COMME INHIBITEURS DE LA HSP90
申请人:NERVIANO MEDICAL SCIENCES SRL
公开号:WO2010121963A1
公开(公告)日:2010-10-28
The present invention relates to substituted resorcinol derivatives which inhibit the activity of Heat Shock Protein HSP90. The compounds of the invention are therefore useful in treating proliferative diseases such as cancer and neurodegenerative diseases. The present invention also provides processes for preparing these compounds, pharmaceutical compositions comprising them, methods of treating diseases and the pharmaceutical compositions comprising these compounds.
The present invention relates to substituted resorcinol derivatives which inhibit the activity of Heat Shock Protein HSP90. The compounds of the invention are therefore useful in treating proliferative diseases such as cancer and neurodegenerative diseases. The present invention also provides processes for preparing these compounds, pharmaceutical compositions comprising them, methods of treating diseases and the pharmaceutical compositions comprising these compounds.
Synthesis of de novo designed small-molecule inhibitors of bacterial RNA polymerase
作者:Anil K. Agarwal、A. Peter Johnson、Colin W.G. Fishwick
DOI:10.1016/j.tet.2008.08.037
日期:2008.10
The denovo molecular design program SPROUT has been used in conjunction with the X-ray crystal structure of RNA polymerase (RNAP) from Thermus aquaticus to produce a novel enzyme inhibitor scaffold. A short and efficient synthesis of molecules corresponding to this scaffold has been developed and in keeping with the design predictions, the resulting inhibitors displayed useful levels of inhibition